Skip to main content
PB Global Limited logo

PB Global Limited — Investor Relations & Filings

Ticker · 506580 ISIN · INE615W01011 LEI · 9845008M5D86564DCE46 BSE.NS Manufacturing
Filings indexed 255 across all filing types
Latest filing 2025-02-12 Regulatory Filings
Country IN India
Listing BSE.NS 506580

About PB Global Limited

https://pbglobal.in/

PB Global Limited is an enterprise engaged in the manufacturing and distribution of a diverse range of chemical products and industrial intermediates. The company focuses on the procurement, processing, and supply of specialty chemicals, organic and inorganic intermediates, and raw materials utilized across various manufacturing sectors. Its operations encompass the sourcing of high-quality chemical components to meet the technical requirements of industrial clients. PB Global Limited emphasizes operational efficiency in its supply chain management and technical expertise in chemical handling. The company's portfolio includes products designed for applications in sectors such as agriculture, pharmaceuticals, and industrial manufacturing, providing essential inputs for complex chemical synthesis and production processes. By leveraging established distribution networks, the firm facilitates the movement of critical chemical commodities to various markets.

Recent filings

Filing Released Lang Actions
approval of quarter ended 31.12.2024 standalone & consolidated financial results
Regulatory Filings
2025-02-12 English
PB Global Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 ,inter alia, to consider and approve approval of unaudited standalone ....
Regulatory Filings
2025-02-04 English
reg 40(10) for Mar 2024
Regulatory Filings
2025-01-22 English
for the quarter 31.12.2024
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming details about physical share certificates received for dematerialization for the quarter ended 31st December 2024. It is a compliance certificate related to share dematerialization and does not contain financial statements, management discussion, or any report content. The document length is short (1273 characters) and it serves as a regulatory attestation rather than a financial or management report. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate.
2025-01-18 English
Appointment of whole time CS and Compliance officer
Regulatory Filings
2025-01-07 English
Appointment of whole time CS and Compliance Officer wef 07.01.2025
Regulatory Filings
2025-01-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.